TG Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:TGTX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -214.51 M-295.63 M-176.17 M-31.41 M-40.52 M-24.77 M -13.95 M Cash from investing activities -24.51 M-332 K-20.01 M-50.65 M-1.04 M13.8 M 16.87 M Cash from financing activities 679.83 M41.42 M-391 K72.7 M128.53 M-89.73 M 307.2 M Free cash flow -214.51 M-295.63 M-176.17 M-31.41 M-40.52 M-24.99 M -14.19 M

News

TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study

Multiple Sclerosis-Focused Biotech Quadruples Its Profit, Raises Sales Forecast

TGTX Stock Rises 29% in 3 Months: Here's What You Should Know

Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders

Stock Market Soars On Tumbling Oil Prices, Strong Earnings: Weekly Review

Nvidia, Amazon, SiTime Among New Names On IBD 50, Stock Spotlight And More

TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View

Dow Jones Futures: Stock Market Hits Highs On Iran-Deal Hopes, Nvidia Leads New Buys; ARM Is Big Earnings Mover

TG Therapeutics (TGTX) Q1 Earnings Lag Estimates

Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth

TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth

TG Therapeutics Stock: Flawless Execution $500M Non-Dilutive Boost Outlook (NASDAQ:TGTX)